In vitro testing for hypersensitivity-mediated adverse drug reactions: Challenges and future directions

Clinical Pharmacology and Therapeutics

Volumn 90, Issue 3, 2011, Pages 455-460

  Elzagallaai, A A ^a   Koren, G ^a   Bend, J R ^a,b   Rieder, M J ^a  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ALLOPURINOL; ANTICONVULSIVE AGENT; AZATHIOPRINE; BETA LACTAM ANTIBIOTIC; CYTOKINE; DAPSONE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; IODINATED CONTRAST MEDIUM; MINOCYCLINE; NEVIRAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TERBINAFINE; TUMOR NECROSIS FACTOR ALPHA;

ANAPHYLAXIS; ARTICLE; ASSAY; BASOPHIL; BASOPHIL ACTIVATION TEST; CLINICAL FEATURE; CYTOTOXICITY TEST; DELAYED HYPERSENSITIVITY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DRUG HYPERSENSITIVITY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; IN VITRO PLATELET TOXICITY ASSAY; IN VITRO STUDY; INTERMETHOD COMPARISON; LYMPHOCYTE TOXICITY ASSAY; LYMPHOCYTE TRANSFORMATION TEST; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; URTICARIA;

BASOPHILS; BLOOD PLATELETS; DRUG HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E; LYMPHOCYTES;

EID: 80052024836     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.155     Document Type: Article

References (40)

1. Davies, E.C., Green, C.F., Taylor, S., Williamson, P.R., Mottram, D.R. & Pirmohamed, M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE 4, e4439 (2009).
2. P irmohamed, M. et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329, 15-19 (2004). (Pubitemid 38869995)
3. Rawlins, M., Thompson, J. Mechanisms of adverse drug reactions. In: Textbook of Adverse Drug Reactions. (ed. Davies, D.) 18-45 (Oxford University Press, Oxford, UK, 1991).
4. P ichler, W. Drug hypersensitivity reactions: Classification and relationship to T-cell activation. In: Drug Hypersensitivity. (ed. Pichler, W.) 168-189 (Karger, Basel, Switzerland, 2007).
5. Coombs, R. & Gell, P. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Clinical Aspects of Immunology. (eds. Gell, P., Coombs, R. & Lachmann, P.) 761-781 (Blackwell, London, 1975).
6. Levine, B.B. & Ovary, Z. Studies on the mechanism of the formation of the penicillin antigen. III. The N-(D-alpha-benzylpenicilloyl) group as an antigenic determinant responsible for hypersensitivity to penicillin G. J. Exp. Med. 114, 875-904 (1961).
7. Elzagallaai, A.A., Rieder, M.J. & Koren, G. The in vitro platelet toxicity assay (iPTA): a novel approach for assessment of drug hypersensitivity syndrome. J. Clin. Pharmacol. 51, 428-435 (2011).
8. Elzagallaai, A.A., Knowles, S.R., Rieder, M.J., Bend, J.R., Shear, N.H. & Koren, G. Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Drug Saf. 32, 391-408 (2009).
9. Elzagallaai, A.A., Garcia-Bournissen, F., Finkelstein, Y., Bend, J.R., Rieder, M.J. & Koren, G. Severe bullous hypersensitivity reactions after exposure to carbamazepine in a Han-Chinese child with a positive HLA-B*1502 and negative in vitro toxicity assays: evidence for different pathophysiological mechanisms. J. Popul. Ther. Clin. Pharmacol. 18, e1-e9 (2011).
10. P eyriie, H. et al.; Network of the French Pharmacovigilance Centers. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br. J. Dermatol. 155, 422-428 (2006).
11. Edwards, R.G., Spackman, D.A. & Dewdney, J.M. Development and use of three new radioallergosorbent tests in the diagnosis of penicillin allergy. Int. Arch. Allergy Appl. Immunol. 68, 352-357 (1982). (Pubitemid 12045069)
12. Fontaine, C. et al. Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy. Allergy 62, 47-52 (2007). (Pubitemid 44902734)
13. Abuaf, N. et al. Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy. J. Allergy Clin. Immunol. 104, 411-418 (1999). (Pubitemid 29420440)
14. T orres, M.J. et al. The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams. Clin. Exp. Allergy 34, 1768-1775 (2004). (Pubitemid 39551532)
15. S anz, M.L., Gamboa, P. & de Weck, A.L. A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int. Arch. Allergy Immunol. 136, 58-72 (2005). (Pubitemid 40187031)
16. De Weck, A.L. et al. Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosis. J. Investig. Allergol. Clin. Immunol. 19, 355-369 (2009).
17. Mayorga, C. et al.; Immunology Committee of the Spanish Society of Allergology and Clinical Immunology of the SEAIC. In vitro diagnosis of immediate allergic reactions to drugs: an update. J. Investig. Allergol. Clin. Immunol. 20, 103-109 (2010).
18. Bircher, A.J. Lymphocyte transformation test in the diagnosis of immediate type hypersensitivity reactions to penicillins. Curr. Probl. Dermatol. 22, 31-37 (1995).
19. Naisbitt, D.J., Williams, D.P., Pirmohamed, M., Kitteringham, N.R. & Park, B.K. Reactive metabolites and their role in drug reactions. Curr. Opin. Allergy Clin. Immunol. 1, 317-325 (2001).
20. Knowles, S.R., Uetrecht, J. & Shear, N.H. Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet 356, 1587-1591 (2000).
21. S hapiro, L.E. & Shear, N.H. Mechanisms of drug reactions: the metabolic track. Semin. Cutan. Med. Surg. 15, 217-227 (1996). (Pubitemid 27197960)
22. Uetrecht, J. Idiosyncratic drug reactions: current understanding. Annu. Rev. Pharmacol. Toxicol. 47, 513-539 (2007).
23. P ichler, W.J., Adam, J., Daubner, B., Gentinetta, T., Keller, M. & Yerly, D. Drug hypersensitivity reactions: pathomechanism and clinical symptoms. Med. Clin. North Am. 94, 645-64, xv (2010).
24. Horton, J.K., Rosenior, J.C., Bend, J.R. & Anderson, M.W. Quantitation of benzo(a)pyrene metabolite: DNA adducts in selected hepatic and pulmonary cell types isolated from [3H]benzo(a)pyrene-treated rabbits. Cancer Res. 45, 3477-3481 (1985). (Pubitemid 15226410)
25. S hear, N.H. & Spielberg, S.P. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J. Clin. Invest. 82, 1826-1832 (1988). (Pubitemid 19054926)
26. S pielberg, S.P., Gordon, G.B., Blake, D.A., Goldstein, D.A. & Herlong, H.F. Predisposition to phenytoin hepatotoxicity assessed in vitro. N. Engl. J. Med. 305, 722-727 (1981). (Pubitemid 11062054)
27. Elzagallaai, A.A., Knowles, S.R., Rieder, M.J., Bend, J.R., Shear, N.H. & Koren, G. In vitro testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Mol. Diagn. Ther. 13, 313-330 (2009).
28. Neuman, M.G., Malkiewicz, I.M. & Shear, N.H. A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes. Clin. Biochem. 33, 517-524 (2000). (Pubitemid 32011860)
29. Elzagallaai, A.A. et al. Predictive value of the lymphocyte toxicity assay in the diagnosis of drug hypersensitivity syndrome. Mol. Diagn. Ther. 14, 317-322 (2010).
30. White, J. Platelet structure. In: Platelets (ed. Michelson, A.) 45-74 (Academic Press, Burlington, MA; 2007).
31. McNicol, A. Platelet preparation and estimation of functional responses. In: Platelets (eds. Watson, S., Authi, K.) 1-26 (Oxford University Press, Oxford, UK, 1996).
32. Capron, A., Joseph, M., Ameisen, J.C., Capron, M., Pancr V. & Auriault, C. Platelets as effectors in immune and hypersensitivity reactions. Int. Arch. Allergy Appl. Immunol. 82, 307-312 (1987). (Pubitemid 17056081)
33. P itchford, S.C. Defining a role for platelets in allergic inflammation. Biochem. Soc. Trans. 35, 1104-1108 (2007). (Pubitemid 350206439)
34. P itchford, S.C. et al. Platelets are essential for leukocyte recruitment in allergic inflammation. J. Allergy Clin. Immunol. 112, 109-118 (2003). (Pubitemid 36819815)
35. T amagawa-Mineoka, R., Katoh, N. & Kishimoto, S. Platelets play important roles in the late phase of the immediate hypersensitivity reaction. J. Allergy Clin. Immunol. 123, 581-7, 587.e1 (2009).
36. Elzagallaai, A., Rieder, M., Koren, G. The in vitro platelet toxicity assay (iPTA): validation of the novel diagnostic test for drug hypersensitivity syndrome. Annual meeting of the American Society for Clinical Pharmacology and Therapeutics; 2-5 March, 2011; Dallas, TX, 2011.
37. Naisbitt, D.J. et al. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drugspecific T cell clones. Mol. Pharmacol. 63, 732-741 (2003). (Pubitemid 36297347)
38. Birchler, A. Approach to the patient with a drug hypersensitivity reactionsclinical perspectives. In: Drug Hypersensitivity ( ed. Pichler, W.) 352-365 (Karger, Basel, Switzerland, 2007).
39. S chnyder, B. Approach to the patient with drug allergy. Med. Clin. North Am. 94, 665-79, xv (2010).
40. P irmohamed, M. Pharmacogenetics of idiosyncratic adverse drug reactions. Handb. Exp. Pharmacol. 196, 477-491 (2010).